Background The optimal treatment of stage I non–small-cell lung carcinoma is subject to
debate. The aim of this study was to compare overall survival and oncologic outcomes of …

Radiotherapy is an attractive treatment option for older adults, especially where surgery and
chemotherapy pose too great a risk. Radiotherapy toxicity may be divided into acute/early …

Objective Older patients with non-small cell lung cancer (NSCLC) are less likely to receive
guideline-recommended treatment at diagnosis, independent of comorbidity. However …

Background On April 15, 2021, the Surveillance, Epidemiology, and End Results (SEER)
database released the latest lung cancer follow-up data. We selected 922,317 lung cancer …

Objectives To compare overall survival (OS) and cancer-specific survival (CSS) outcomes of
surgery with radiotherapy in octogenarians with stage Ia non-small cell lung cancer …

Objectives. Uncertainty in survival prediction beyond trial follow-up is highly influential in
cost-effectiveness analyses of oncology products. This research provides an empirical …

Non–small cell lung cancer is the most common malignancy in males; it constitutes the
majority of lung cancer cases and requires massive medical resources. Despite …

Introduction Surgery improves survival of small-cell lung cancer (SCLC) patients in early
stage. However, the role of surgery in the elderly stage I SCLC patients is not well …

Purpose To analyze outcomes of stereotactic body radiotherapy (SBRT) for operable
patients with early-stage non-small cell lung cancer (NSCLC) and to evaluate factors …

Background The proportion of the elderly (≥ 80 years old) patient population in the United
States is increasing. Consequently, surgeons are more involved in the care of these patients …